AR018868A1 - Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche - Google Patents

Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche

Info

Publication number
AR018868A1
AR018868A1 ARP990102847A ARP990102847A AR018868A1 AR 018868 A1 AR018868 A1 AR 018868A1 AR P990102847 A ARP990102847 A AR P990102847A AR P990102847 A ARP990102847 A AR P990102847A AR 018868 A1 AR018868 A1 AR 018868A1
Authority
AR
Argentina
Prior art keywords
fragility
compositions
medicines
preparation
case
Prior art date
Application number
ARP990102847A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR018868A1 publication Critical patent/AR018868A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ARP990102847A 1998-06-16 1999-06-15 Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche AR018868A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
AR018868A1 true AR018868A1 (es) 2001-12-12

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102847A AR018868A1 (es) 1998-06-16 1999-06-15 Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche

Country Status (29)

Country Link
EP (1) EP1085867A1 (zh)
JP (1) JP2002518328A (zh)
KR (1) KR20010052817A (zh)
CN (1) CN1305378A (zh)
AP (1) AP9901581A0 (zh)
AR (1) AR018868A1 (zh)
AU (1) AU3342099A (zh)
BG (1) BG105128A (zh)
BR (1) BR9911357A (zh)
CA (1) CA2335112A1 (zh)
CO (1) CO5070586A1 (zh)
EA (1) EA200001189A1 (zh)
GT (1) GT199900083A (zh)
HR (1) HRP20000857A2 (zh)
HU (1) HUP0102395A2 (zh)
ID (1) ID26726A (zh)
IL (1) IL139587A0 (zh)
IS (1) IS5727A (zh)
MA (1) MA26648A1 (zh)
NO (1) NO20006381L (zh)
OA (1) OA11569A (zh)
PA (1) PA8472101A1 (zh)
PE (1) PE20000633A1 (zh)
PL (1) PL345064A1 (zh)
SK (1) SK18902000A3 (zh)
TN (1) TNSN99118A1 (zh)
UY (1) UY25557A1 (zh)
WO (1) WO1999065488A1 (zh)
ZA (1) ZA993973B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
EP1666033B1 (en) * 2001-11-29 2008-12-31 GTX, Inc. Prevention and treatment of androgen-deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID26726A (id) 2001-02-01
PL345064A1 (en) 2001-11-19
EP1085867A1 (en) 2001-03-28
TNSN99118A1 (fr) 2005-11-10
IL139587A0 (en) 2002-02-10
NO20006381D0 (no) 2000-12-14
GT199900083A (es) 2000-12-05
AU3342099A (en) 2000-01-05
WO1999065488A1 (en) 1999-12-23
SK18902000A3 (sk) 2001-12-03
CA2335112A1 (en) 1999-12-23
BG105128A (en) 2001-11-30
HUP0102395A2 (hu) 2001-11-28
EA200001189A1 (ru) 2001-06-25
MA26648A1 (fr) 2004-12-20
JP2002518328A (ja) 2002-06-25
KR20010052817A (ko) 2001-06-25
ZA993973B (en) 2000-12-15
CO5070586A1 (es) 2001-08-28
OA11569A (en) 2004-07-01
CN1305378A (zh) 2001-07-25
BR9911357A (pt) 2001-03-13
HRP20000857A2 (en) 2001-10-31
AP9901581A0 (en) 1999-06-30
IS5727A (is) 2000-11-24
PE20000633A1 (es) 2000-07-26
UY25557A1 (es) 2001-01-31
PA8472101A1 (es) 2000-09-29
NO20006381L (no) 2000-12-14

Similar Documents

Publication Publication Date Title
EE04018B1 (et) Tieno[2,3-d]pürimidiindioonid, nende valmistamisemeetod ja neid sisaldavad ravimkoostised
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
BG111017A (bg) Нови кристални и аморфна форми на съединението триазоло (4, 5- d)пиримидин
ID22746A (id) Senyawa-senyawa baru
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
NO993027L (no) Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler
HUP0001632A2 (hu) Szelektív foszfodiészteráz PDE enzim inhibitort tartalmazó gyógyszerkészítmények
AR018868A1 (es) Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche
AU2003288869A1 (en) PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
AR018869A1 (es) Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
NO20023249D0 (no) Nye substituerte pyrazolo(4,3-e)ediazepiner, farmasöytiske preparater inneholdende disse, anvendelse som medisinske produkterog fremgangsmåter for fremstilling derav
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
ES2126534B1 (es) Composicion base para la elaboracion de productos cosmeticos.
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
SE0100296D0 (sv) New compounds
ATE301455T1 (de) Pharmazeutische zubereitung enthaltend valaciclovir

Legal Events

Date Code Title Description
FA Abandonment or withdrawal